Healthcare provider profile · identity verified

Manuel E Melendez Ramirez, MD

General Practice · MANATI, PR · NPI 1346280906

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Famotidine	Famotidine	591	168
Gabapentin	Gabapentin	546	209
Omeprazole	Omeprazole	354	88
Atorvastatin Calcium	Atorvastatin Calcium	349	149
Synthroid	Levothyroxine Sodium	348	120
Losartan Potassium	Losartan Potassium	332	142
Rosuvastatin Calcium	Rosuvastatin Calcium	317	138
Amlodipine Besylate	Amlodipine Besylate	316	143
Metformin Hcl	Metformin Hcl	289	126
Clonazepam	Clonazepam	253	45
Simvastatin	Simvastatin	253	103
Pantoprazole Sodium	Pantoprazole Sodium	241	65
Temazepam	Temazepam	235	55
Hydrochlorothiazide	Hydrochlorothiazide	172	81
Metoprolol Succinate	Metoprolol Succinate	161	69
Tamsulosin Hcl	Tamsulosin Hcl	161	76
Lisinopril	Lisinopril	154	65
Glimepiride	Glimepiride	138	58
Fluticasone Propionate	Fluticasone Propionate	104	70
Prednisone	Prednisone	101	74
Finasteride	Finasteride	98	43
Montelukast Sodium	Montelukast Sodium	96	43
Baclofen	Baclofen	95	68
Clopidogrel	Clopidogrel Bisulfate	94	40
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	93	48
Glipizide	Glipizide	88	29
Alendronate Sodium	Alendronate Sodium	84	38
Ezetimibe	Ezetimibe	84	40
Trazodone Hcl	Trazodone Hcl	79	30
Lantus	Insulin Glargine,hum.Rec.Anlog	78	23
Jentadueto	Linagliptin/Metformin Hcl	74	13
Diclofenac Potassium	Diclofenac Potassium	73	50
Enalapril Maleate	Enalapril Maleate	66	24
Warfarin Sodium	Warfarin Sodium	65	suppressed
Farxiga	Dapagliflozin Propanediol	64	12
Levothyroxine Sodium	Levothyroxine Sodium	62	29
Carvedilol	Carvedilol	59	25
Xarelto	Rivaroxaban	57	12
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	55	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	55	29
Nabumetone	Nabumetone	54	31
Albuterol Sulfate Hfa	Albuterol Sulfate	53	26
Janumet	Sitagliptin Phos/Metformin Hcl	53	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	50	47
Cilostazol	Cilostazol	50	26
Dexamethasone	Dexamethasone	50	40
Irbesartan	Irbesartan	50	24
Ciprofloxacin Hcl	Ciprofloxacin Hcl	48	43
Dicyclomine Hcl	Dicyclomine Hcl	48	28
Metoprolol Tartrate	Metoprolol Tartrate	48	17
Sertraline Hcl	Sertraline Hcl	48	25
Meclizine Hcl	Meclizine Hcl	46	20
Pentoxifylline	Pentoxifylline	45	18
Sulindac	Sulindac	44	32
Furosemide	Furosemide	43	22
Hydralazine Hcl	Hydralazine Hcl	43	20
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	41	14
Colchicine	Colchicine	40	suppressed
Sucralfate	Sucralfate	40	22
Methylprednisolone	Methylprednisolone	39	39
Jardiance	Empagliflozin	38	suppressed
Humalog	Insulin Lispro	37	11
Eliquis	Apixaban	35	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	34	30
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	34	13
Alprazolam	Alprazolam	33	suppressed
Mupirocin	Mupirocin	33	29
Spironolactone	Spironolactone	33	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	15
Nifedipine Er	Nifedipine	32	suppressed
Lansoprazole	Lansoprazole	31	suppressed
Levofloxacin	Levofloxacin	31	27
Diclofenac Sodium	Diclofenac Sodium	30	22
Allopurinol	Allopurinol	28	12
Azithromycin	Azithromycin	28	28
Entresto	Sacubitril/Valsartan	28	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	27	11
Insulin Syringe	Syringe And Needle,insulin,1ml	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	11
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	25	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	12
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Ibandronate Sodium	Ibandronate Sodium	23	14
Ondansetron Hcl	Ondansetron Hcl	23	12
Tradjenta	Linagliptin	23	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	22	suppressed
Cefadroxil	Cefadroxil	21	21
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	21	suppressed
Latanoprost	Latanoprost	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Atenolol	Atenolol	20	suppressed
Donepezil Hcl	Donepezil Hcl	20	11
Gemfibrozil	Gemfibrozil	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	19	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	12
Hydroxyzine Pamoate	Hydroxyzine Pamoate	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Ciclopirox	Ciclopirox	18	11
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Orphenadrine Citrate Er	Orphenadrine Citrate	18	16
Tramadol Hcl	Tramadol Hcl	18	14
Clonidine Hcl	Clonidine Hcl	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	12
Pen Needle	Pen Needle, Diabetic	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Clotrimazole	Clotrimazole	16	13
Dovato	Dolutegravir Sodium/Lamivudine	16	suppressed
Estradiol	Estradiol	16	suppressed
Humulin N	Insulin Nph Human Isophane	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Topiramate	Topiramate	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Mometasone Furoate	Mometasone Furoate	15	13
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Repatha Sureclick	Evolocumab	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Clindamycin Hcl	Clindamycin Hcl	14	13
Naproxen	Naproxen	14	suppressed
Sure Comfort	Syringe-Needle,insulin,0.5 Ml	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Fluconazole	Fluconazole	13	12
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	12	suppressed
Jentadueto Xr	Linagliptin/Metformin Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Phenobarbital	Phenobarbital	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error